Dany Vaiman Amends Flora Growth Corp. Filing

Ticker: ZSTK · Form: SC 13D/A · Filed: Dec 17, 2024 · CIK: 1790169

Flora Growth Corp. SC 13D/A Filing Summary
FieldDetail
CompanyFlora Growth Corp. (ZSTK)
Form TypeSC 13D/A
Filed DateDec 17, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: FLGC

TL;DR

Vaiman updated his 13D for Flora Growth (FLGC) - check for ownership changes.

AI Summary

Dany Vaiman has filed an amendment (Amendment No. 1) to Schedule 13D for Flora Growth Corp. on December 15, 2024. The filing pertains to the common shares of Flora Growth Corp. and indicates a change in beneficial ownership. The filing was made under the Securities Exchange Act of 1934.

Why It Matters

This filing signals a potential shift in control or significant stake changes for Flora Growth Corp., which could impact its stock price and strategic direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and strategic shifts for the company.

Key Numbers

  • December 15, 2024 — Filing Date (Date of the event requiring this filing)

Key Players & Entities

  • Dany Vaiman (person) — Filing person and authorized contact
  • Flora Growth Corp. (company) — Subject company
  • Dorsey & Whitney LLP (company) — Legal counsel for notice recipient

FAQ

What specific changes in beneficial ownership are detailed in this Amendment No. 1 to Schedule 13D?

The provided text is the header and does not contain the specific details of the ownership changes, only that an amendment was filed.

Who is the primary filer for this Schedule 13D/A?

Dany Vaiman is listed as the filing person.

What is the CUSIP number for Flora Growth Corp. common shares mentioned in the filing?

The CUSIP number is 339764102.

What is the business address of Flora Growth Corp. as listed in the filing?

The business address is 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, FL 33309.

Under which SEC Act was this Schedule 13D/A filed?

This filing was made under the Securities Exchange Act of 1934.

Filing Stats: 1,229 words · 5 min read · ~4 pages · Grade level 14.1 · Accepted 2024-12-17 20:01:40

Filing Documents

From the Filing

SC 13D/A 1 ef20040312_sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 Flora Growth Corp. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 339764102 (CUSIP Number) Dany Vaiman Flora Growth Corp. 3230 W. Commercial Blvd., Suite 180 Fort Lauderdale, FL 33309 With a copy to: Richard Raymer Dorsey & Whitney LLP 66 Wellington Street W., Suite 3400 Toronto, Ontario M5K 1E6 Canada (416) 367-7370 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 15, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 339764102 1 NAMES OF REPORTING PERSONS Dany Vaiman (the "Reporting Person") 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (SEE INSTRUCTIONS) OO 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E) Not Applicable 6 CITIZENSHIP OR PLACE OF ORGANIZATION Canada NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 1,078,011 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 1,078,011 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,078,011 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) NOT APPLICABLE 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.6% (1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) IN (1) The percentages used herein are calculated based on 18,511,898 outstanding shares of the Issuer as of December 15, 2024, plus 907,161 shares underlying stock appreciation rights held by the Reporting Person. CUSIP No. 339764102 This Statement constitutes Amendment No. 1 to the Schedule 13D filed with the Securities and Exchange Commission (" SEC ") on September 12, 2024 (the " Original Schedule 13D "), as amended through to the date hereof (the " Amended Schedule 13D "), with respect to the Common Shares of Flora Growth Corp. (the " Issuer "), held by Dany Vaiman (the " Reporting Person "). Except as set forth below, all Items of the Original Schedule 13D remain unchanged. Item 1. Security and Issuer (a) Title of Class of Securities: Common Shares, no par value (b) Name of Issuer: Flora Growth Corp., an Ontario corporation (c) Address of Issuer's Principal Executive Offices: 3230 W. Commercial Blvd., Suite 180 Fort Lauderdale, FL 33309 Item 2. Identity and Background (a) Name of Reporting Person: Dany Vaiman (b) Principal Business Address: The principal business address of the Reporting Persons is: 3230 W. Commercial Blvd., Suite 180, Fort Lauderdale, FL 33309 (c) Occupation, Employment and Other Information: The Reporting Person is the Chief Financial Officer of the Issuer. (d) Criminal convictions: The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) Civil proceedings: The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which the Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Citizenship: Canada Item 3. Source and Amount of Funds or Other Consideration: OO – Issuer grant of stock appreciation rights pursuant to Issuer's 2022 Incentive Compensation Plan Item 4. Purpose of Transaction The transaction described in Item 5(c) below was made in the ordinary course of business and the Reporting Person has no plans or proposals regarding the acquisiti

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.